Diabetes

Protein reveals diabetes risk many years in advance

When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who ...

Oncology & Cancer

Team discovers broken 'brake' of cancer mutation machine

Loss of a gene known as SYNCRIP in prostate cancer tumors unleashes cellular machinery that creates random mutations throughout the genome that drive resistance to targeted treatments, a team led by UT Southwestern Medical ...

Other

Eli Lilly to acquire Loxo Oncology for $8 billion

Pharmaceutical giant Eli Lilly announced Monday it will acquire Loxo Oncology for around $8 billion, the latest big transaction aimed at developing and monetizing new treatments for cancer.

Diabetes

Microaneurysm turnover IDs macular edema development

(HealthDay)—Microaneurysm (MA) turnover independently predicts the development of clinically significant macular edema (CSME) in patients with non-proliferative diabetic retinopathy (NPDR), according to a study published ...

Oncology & Cancer

Shining new light on immunotherapy for breast cancer

Immunotherapy that enhances the body's immune response has transformed the landscape for cancer treatment. These treatments have led to unprecedented survival outcomes in some cancer types, but not all patients are seeing ...

Diabetes

Diabetes patients need to be consulted to improve treatment

Patients with type 2 diabetes who tailor their own treatment in cooperation with their doctor can reduce their risk of complications such as heart attack with up to 20 percent. This is the result of a new Danish study from ...

page 8 from 9